recombinant factor VIII concentrate

recombinant factor VIII concentrate

a concentrate of factor VIII prepared by recombinant DNA technology used to treat bleeding in hemophilia A patients (factor VIII deficiency). See FVIII.
Mentioned in ?
References in periodicals archive ?
Contract award: recombinant factor viii concentrate at least second generation, the investigation sign: zzp-129/15.
Historically, Baxter has been at the forefront of hemophilia care through the development of products such as ADVATE, the first recombinant factor VIII concentrate processed without the addition of animal or human blood components," said Norbert Riedel, Ph.
Contract notice: Recombinant factor viii concentrate ii generation, the investigation sign: zzp-129/15.
This is more than twice the distribution within a similar post-launch time frame for RECOMBINATE, which went on to become a leading recombinant Factor VIII concentrate.
In the 1980s Baxter introduced the first heat-treated factor VIII concentrate available in the United States, and later pioneered the first recombinant factor VIII concentrate.
It produces the recombinant Factor VIII concentrate used in the manufacture of Baxter Healthcare Corp.

Full browser ?